利润表
PALVELLA THERAPEUTICS, INC.
PVLA
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Jun 30, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | 42.81 | 25.90 | 31.42 | 29.32 | 48.59 | 29.10 | 25.28 | 20.00 | 2.93 | 0.00 |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | 42.81 | 25.90 | 31.42 | 29.32 | 48.59 | 29.10 | 25.28 | 20.00 | 2.93 | - |
|
营业费用
|
38.60 | 14.10 | 72.57 | 69.38 | 83.25 | 63.24 | 73.44 | 59.93 | 39.87 | 28.59 | 16.61 | 0.02 |
|
研发费用
|
22.84 | 8.15 | 41.80 | 52.98 | 66.66 | 46.53 | 55.00 | 41.49 | 22.29 | 19.70 | 8.24 | - |
|
销售、一般及行政费用
|
15.76 | 5.94 | 16.85 | 16.39 | 16.59 | 16.71 | 18.44 | 18.44 | 17.58 | 8.89 | 8.37 | 0.00 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-38.60 | -14.10 | -29.76 | -43.47 | -51.83 | -33.92 | -24.84 | -30.83 | -14.59 | -8.59 | -13.68 | -0.02 |
|
营业外收入
|
3.11 | 3.34 | - | - | -6.09 | 3.15 | 0.63 | -3.77 | 1.95 | 14.05 | 0.17 | - |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
0.00 | 0.43 | - | - | - | - | - | - | - | - | 0.00 | - |
|
其他营业外收入/支出
|
0.73 | 0.51 | -0.25 | 1.30 | 2.40 | -3.66 | -0.03 | 1.80 | -2.10 | 0.12 | 0.01 | - |
|
税前利润
|
-41.72 | -17.43 | -24.54 | -33.28 | -45.74 | -37.07 | 1.46 | -27.07 | -16.54 | -22.64 | -13.85 | - |
|
所得税费用
|
0.00 | 0.00 | - | - | 0.00 | 0.16 | 0.00 | -0.31 | 1.10 | 0.16 | 0.20 | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-41.72 | -17.43 | -24.54 | 0.00 | -45.74 | -37.23 | -25.47 | -26.75 | -17.65 | -22.80 | -14.06 | -0.02 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Jun 30, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-38.60 | -14.10 | -27.85 | -40.70 | -51.83 | -33.92 | -24.84 | -30.83 | -14.59 | -8.59 | -13.68 | -0.02 |
|
基本每股收益
|
-3.71 | -7.83 | -0.27 | -0.45 | -0.71 | - | - | - | - | - | - | - |
|
稀释每股收益
|
-3.71 | -7.83 | - | - | -0.71 | - | - | - | - | - | - | - |
|
加权平均股数
|
11.25 | 2.23 | 90.06 | 74.17 | 64.55 | - | - | - | - | - | - | 6.10 |
|
稀释加权平均股数
|
11.25 | 2.23 | - | - | 64.55 | - | - | - | - | - | - | - |
|
综合收益
|
-41.64 | -17.43 | -24.26 | -34.36 | -44.61 | -35.53 | 1.46 | -25.04 | -20.84 | -23.03 | -14.49 | - |